Selegilinum

E Vicipaedia
Jump to navigation Jump to search
Esculaap4.svg
Cave: notitiae huius paginae nec praescriptiones nec consilia medica sunt.
Selegilinum
Cognitores
ChemSpider 24930
PubChem 26757
DrugBank DB01037
Natura chemica
Selegilinum
Selegilinum
Formula chemica C
13
H
17
N
Massa molaris 187.281 g/mol
Natura pharmacologica
Codex ATC N04BD01 (WHO)
QN06AX90 (WHO)
Semivita biologica 10 h (per os)
18-25 h (trans dermem)
Metaboliti N-Desmethyl-
selegilinm
L-amphetaminum
L-methamphetaminum
Excretio renibus
Ad usum therapeuticum
Applicatio per os
MedlinePlus a667046 (Anglice)

Selegilinum est medicamentum pharmaceuticum et inhibitor monoaminorum oxidasis B irreversibilis. Substantia in morbo Parkinson tractando et maturo et in cursibus progressivis adhibeatur.

Natura Selegilini[recensere | fontem recensere]

Natura chemica[recensere | fontem recensere]

Nomen suum est (R)-N-methyl-1-phenyl-N-prop-2-inyl-propanum-2-aminum. Massa molaris sua 187.281 g/mol.

Natura pharmacologica[recensere | fontem recensere]

Selegilinum est MAO-B inhibitor irreversibilis et medicamentum therapia morbi Parkinson[1] et maturi et progressivi.

Notae[recensere | fontem recensere]

  1. Ives N. J., Stowe R. L., Marro J., Counsell C., Macleod A., Clarke C. E., Gray R., Wheatley K. (Sep 2004). "Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients". BMJ 329 (7466): 593 

Nexus interni

Mexus externi[recensere | fontem recensere]